We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$395B
AUM Growth
+$8.56B
Cap. Flow
-$360M
Cap. Flow %
-0.09%
Top 10 Hldgs %
27.43%
Holding
14,748
New
1,670
Increased
4,598
Reduced
5,764
Closed
2,486

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.29%
2 Technology 2.06%
3 Consumer Discretionary 1.55%
4 Financials 1.15%
5 Healthcare 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHAB
12626
DELISTED
Enhabit
EHAB
-11,786
Closed -$165K
EHC icon
12627
PUT
Encompass Health
EHC
$11.8B
-9,100
Closed -$412K
EHI
12628
Western Asset Global High Income Fund
EHI
$173M
-12,876
Closed -$84K
EJAN icon
12629
Innovator Emerging Markets Power Buffer ETF January
EJAN
$150M
-22,301
Closed -$556K
EJH icon
12630
E-Home Household Service Holdings
EJH
$4.22M
0
-$8K
CHRN
12631
ChronoScale Holdings
CHRN
$3.01B
-764
Closed -$18K
CHRN
12632
PUT
ChronoScale Holdings
CHRN
$3.01B
-927
Closed -$22K
ELDN icon
12633
CALL
Eledon Pharmaceuticals
ELDN
$270M
-14,500
Closed -$40K
ELME
12634
Elme Communities
ELME
$148M
-30,388
Closed -$534K
ELTX icon
12635
Elicio Therapeutics
ELTX
$78.8M
-1,366
Closed -$13K
ELVN icon
12636
PUT
Enliven Therapeutics
ELVN
$4.43B
-18,075
Closed -$165K
EMBD icon
12637
Global X Emerging Markets Bond ETF
EMBD
$250M
-13,741
Closed -$273K
EMIF icon
12638
iShares Emerging Markets Infrastructure ETF
EMIF
$13.1M
-13,770
Closed -$261K
EMQQ icon
12639
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$265M
-43,462
Closed -$1.18M
EMXC icon
12640
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.1B
-130,990
Closed -$5.8M
ENB icon
12641
Enbridge
ENB
$109B
-18,790
Closed -$735K
ENOR icon
12642
iShares MSCI Norway ETF
ENOR
$90M
-23,551
Closed -$490K
ENTA icon
12643
PUT
Enanta Pharmaceuticals
ENTA
$403M
-5,500
Closed -$285K
ENSG icon
12644
PUT
The Ensign Group
ENSG
$10.1B
-6,900
Closed -$549K
ENVA icon
12645
CALL
Enova International
ENVA
$5.91B
-16,200
Closed -$474K
ENVA icon
12646
Enova International
ENVA
$5.91B
-25,626
Closed -$750K
ENVA icon
12647
PUT
Enova International
ENVA
$5.91B
-14,300
Closed -$419K
ENZL icon
12648
iShares MSCI New Zealand ETF
ENZL
$84.9M
-31,699
Closed -$1.44M
EPI icon
12649
CALL
WisdomTree India Earnings Fund ETF
EPI
$2.03B
-17,100
Closed -$522K
EPI icon
12650
WisdomTree India Earnings Fund ETF
EPI
$2.03B
-15,945
Closed -$517K

Similar funds

Jeff Yass's Q4 2022 Portfolio in Review

As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
  • Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
  • Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
  • Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
  • Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
  • Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
  • Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.